Petros K. Tsantoulis

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 29, 2026

Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 29, 2026

Intensification of radio-hormone therapy for prostate cancer

Intensification of radio-hormone therapy for prostate cancer

Journal: Revue medicale suisse

Published: May 18, 2026

Censoring patterns and inconsistent results in checkpoint inhibitor and adjuvant BCG trials for high-risk bladder cancer.

Censoring patterns and inconsistent results in checkpoint inhibitor and adjuvant BCG trials for high-risk bladder cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 16, 2026

Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.

Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.

Journal: NPJ precision oncology

Published: October 07, 2025

Title Not Found

Title Not Found

Journal: Sante publique (Vandoeuvre-les-Nancy, France)

Published: October 06, 2025

Modeling CAF-tumor interactions to overcome therapy resistance.

Modeling CAF-tumor interactions to overcome therapy resistance.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 24, 2025

A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer.

A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer.

Journal: Journal of translational medicine

Published: July 17, 2025

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Journal: Cell reports. Medicine

Published: June 20, 2025

Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency: A Diagnostic Challenge.

Concomitant Immune Checkpoint Inhibitors Induced Central and Primary Adrenal Insufficiency: A Diagnostic Challenge.

Journal: JCEM case reports

Published: June 12, 2025

Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer.

Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer.

Journal: iScience

Published: June 11, 2025

Precision oncology in rare tumors: Have the orphans been adopted?

Precision oncology in rare tumors: Have the orphans been adopted?

Journal: Med (New York, N.Y.)

Published: June 04, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026